MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1
出版年份 2016 全文链接
标题
MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1
作者
关键词
-
出版物
ONCOGENE
Volume 35, Issue 48, Pages 6189-6202
出版商
Springer Nature
发表日期
2016-05-09
DOI
10.1038/onc.2016.151
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A Significant Metabolic and Radiological Response after a Novel Targeted MicroRNA-based Treatment Approach in Malignant Pleural Mesothelioma
- (2015) Steven C. Kao et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Loss of RACK1 Promotes Metastasis of Gastric Cancer by Inducing a miR-302c/IL8 Signaling Loop
- (2015) Ling Chen et al. CANCER RESEARCH
- Targeting of YAP1 by microRNA-15a and microRNA-16-1 exerts tumor suppressor function in gastric adenocarcinoma
- (2015) Wei Kang et al. Molecular Cancer
- The miR-15 Family Enhances the Radiosensitivity of Breast Cancer Cells by Targeting G2Checkpoints
- (2015) Zijie Mei et al. RADIATION RESEARCH
- MicroRNAome genome: A treasure for cancer diagnosis and therapy
- (2014) Ioana Berindan-Neagoe et al. CA-A CANCER JOURNAL FOR CLINICIANS
- ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics
- (2014) Carlos L. Arteaga et al. CANCER CELL
- A critical review of HER2-positive gastric cancer evaluation and treatment: From trastuzumab, and beyond
- (2014) Carlos Gomez-Martín et al. CANCER LETTERS
- MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-κB1/MMP9 signaling pathway
- (2014) Tian-Quan Yang et al. CANCER SCIENCE
- HER2 aberrations in cancer: Implications for therapy
- (2014) Min Yan et al. CANCER TREATMENT REVIEWS
- A microRNA 221– and 222–Mediated Feedback Loop Maintains Constitutive Activation of NFκB and STAT3 in Colorectal Cancer Cells
- (2014) Sanhong Liu et al. GASTROENTEROLOGY
- A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression
- (2014) N. Okada et al. GENES & DEVELOPMENT
- Regulation of Human Growth Hormone Receptor Expression by MicroRNAs
- (2014) Samar Elzein et al. MOLECULAR ENDOCRINOLOGY
- Growth factor receptor/steroid receptor cross talk in trastuzumab-treated breast cancer
- (2014) D C Collins et al. ONCOGENE
- Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance
- (2014) R I Cordo Russo et al. ONCOGENE
- Expression of growth hormone receptor, plakoglobin and NEDD9 protein in association with tumour progression and metastasis in human breast cancer
- (2014) Emil Štajduhar et al. TUMOR BIOLOGY
- MicroRNA-16 Inhibits Bladder Cancer Proliferation by Targeting Cyclin D1
- (2013) Qi-Quan Jiang et al. Asian Pacific Journal of Cancer Prevention
- Prooncogenic Factors miR-23b and miR-27b Are Regulated by Her2/Neu, EGF, and TNF- in Breast Cancer
- (2013) L. Jin et al. CANCER RESEARCH
- MEK Inhibition Increases Lapatinib Sensitivity Via Modulation of FOXM1
- (2013) S.S. Gayle et al. CURRENT MEDICINAL CHEMISTRY
- miR-16 inhibits cell proliferation by targeting IGF1R and the Raf1-MEK1/2-ERK1/2 pathway in osteosarcoma
- (2013) Lei Chen et al. FEBS LETTERS
- miR-125b Acts as a Tumor Suppressor in Breast Tumorigenesis via Its Novel Direct Targets ENPEP, CK2-α, CCNJ, and MEGF9
- (2013) Andrea Feliciano et al. PLoS One
- Identification of FDA-approved Drugs Targeting Breast Cancer Stem Cells Along With Biomarkers of Sensitivity
- (2013) Poornima Bhat-Nakshatri et al. Scientific Reports
- Multiple microRNAs induced by Cdx1 suppress Cdx2 in human colorectal tumour cells
- (2012) Takanobu Tagawa et al. BIOCHEMICAL JOURNAL
- Induction of cell proliferation and survival genes by estradiol-repressed microRNAs in breast cancer cells
- (2012) Xinfeng Yu et al. BMC CANCER
- Vector-based miR-15a/16-1 plasmid inhibits colon cancer growthin vivo
- (2012) Lixia Dai et al. CELL BIOLOGY INTERNATIONAL
- Far upstream element binding protein 1: a commander of transcription, translation and beyond
- (2012) J Zhang et al. ONCOGENE
- MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors
- (2012) Long R. Jiao et al. PLoS One
- Trastuzumab Produces Therapeutic Actions by Upregulating miR-26a and miR-30b in Breast Cancer Cells
- (2012) Takehiro Ichikawa et al. PLoS One
- Modulation of MicroRNA-194 and Cell Migration by HER2-Targeting Trastuzumab in Breast Cancer
- (2012) Xiao-Feng Le et al. PLoS One
- Cyclooxygenase-2 Is a Target of MicroRNA-16 in Human Hepatoma Cells
- (2012) Noelia Agra Andrieu et al. PLoS One
- MicroRNA-16 and MicroRNA-424 Regulate Cell-Autonomous Angiogenic Functions in Endothelial Cells via Targeting Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1
- (2011) Aránzazu Chamorro-Jorganes et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- miRNA-34a is associated with docetaxel resistance in human breast cancer cells
- (2011) L. Kastl et al. BREAST CANCER RESEARCH AND TREATMENT
- MicroRNA-125a-5p Is an Independent Prognostic Factor in Gastric Cancer and Inhibits the Proliferation of Human Gastric Cancer Cells in Combination with Trastuzumab
- (2011) N. Nishida et al. CLINICAL CANCER RESEARCH
- HER2 Interacts With CD44 to Up-regulate CXCR4 via Epigenetic Silencing of microRNA-139 in Gastric Cancer Cells
- (2011) Wei Bao et al. GASTROENTEROLOGY
- Differential Regulation of N-Myc and c-Myc Synthesis, Degradation, and Transcriptional Activity by the Ras/Mitogen-activated Protein Kinase Pathway
- (2011) Katannya Kapeli et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas
- (2011) X Zhang et al. ONCOGENE
- miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors
- (2011) Espen Enerly et al. PLoS One
- Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+breast cancer patients
- (2011) Maurizio Scaltriti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase
- (2011) J. T. Garrett et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib
- (2010) Giorgio Valabrega et al. BREAST CANCER RESEARCH AND TREATMENT
- Multiple molecular mechanisms underlying trastuzumab and lapatinib resistance in JIMT-1 breast cancer cells
- (2010) Katri Köninki et al. CANCER LETTERS
- Oncogenic HER2Δ16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors
- (2010) Diana M. Cittelly et al. CARCINOGENESIS
- Activated Phosphoinositide 3-Kinase/AKT Signaling Confers Resistance to Trastuzumab but not Lapatinib
- (2010) N. A. O'Brien et al. MOLECULAR CANCER THERAPEUTICS
- Transactivation of ErbB-2 induced by tumor necrosis factor α promotes NF-κB activation and breast cancer cell proliferation
- (2009) Martín A. Rivas et al. BREAST CANCER RESEARCH AND TREATMENT
- MiR-15a and MiR-16 Control Bmi-1 Expression in Ovarian Cancer
- (2009) R. Bhattacharya et al. CANCER RESEARCH
- miR-15a and miR-16 Are Implicated in Cell Cycle Regulation in a Rb-Dependent Manner and Are Frequently Deleted or Down-regulated in Non–Small Cell Lung Cancer
- (2009) Nora Bandi et al. CANCER RESEARCH
- Elevation of Receptor Tyrosine Kinase EphA2 Mediates Resistance to Trastuzumab Therapy
- (2009) G. Zhuang et al. CANCER RESEARCH
- Suppression of HER2/HER3-Mediated Growth of Breast Cancer Cells with Combinations of GDC-0941 PI3K Inhibitor, Trastuzumab, and Pertuzumab
- (2009) E. Yao et al. CLINICAL CANCER RESEARCH
- Up-regulation of miR-21 by HER2/neuSignaling Promotes Cell Invasion
- (2009) Tzu-Hsuan Huang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Understanding the Mechanisms Behind Trastuzumab Therapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
- (2009) Neil L. Spector et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular predictors of response to trastuzumab and lapatinib in breast cancer
- (2009) Francisco J. Esteva et al. Nature Reviews Clinical Oncology
- Far upstream element-binding protein-1, a novel caspase substrate, acts as a cross-talker between apoptosis and the c-myc oncogene
- (2009) M Jang et al. ONCOGENE
- The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti-HER-2 Therapy and Personalized Medicine
- (2009) J. S. Ross et al. ONCOLOGIST
- Expression of t-DARPP Mediates Trastuzumab Resistance in Breast Cancer Cells
- (2008) A. Belkhiri et al. CLINICAL CANCER RESEARCH
- miRecords: an integrated resource for microRNA-target interactions
- (2008) F. Xiao et al. NUCLEIC ACIDS RESEARCH
- Brk is coamplified with ErbB2 to promote proliferation in breast cancer
- (2008) B. Xiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search